Literature DB >> 1559254

Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients.

P Sarchielli1, G Coata, C Firenze, P Morucci, G Abbritti, V Gallai.   

Abstract

It has been suggested that magnesium plays a central role in different etiopathogenetic conditions involved in the onset of migraine. We measured, by atomic absorption spectrophotometry, serum and salivary magnesium levels in drug-free migraine patients with and without aura and in tension-type headache patients. Migraine sufferers with and without aura and tension-type headache had significantly lower levels of serum and salivary magnesium concentrations in the interical periods than a group of healthy young individuals. Serum magnesium levels tended to be further reduced during attacks in all patient groups studied. A statistically significant decrease in salivary magnesium levels was evident only for migraine patients with aura. Serum magnesium levels and to a lesser extent salivary magnesium levels might express indirectly the lowering of brain extracellular magnesium concentration which occurs in migraine patients both in the intererictal periods and ictally.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1559254     DOI: 10.1046/j.1468-2982.1992.1201021.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  10 in total

Review 1.  Glutamate and Its Receptors as Therapeutic Targets for Migraine.

Authors:  Jan Hoffmann; Andrew Charles
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 2.  Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Authors:  Till Sprenger; M Viana; C Tassorelli
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 3.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

4.  Blood Magnesium levels in migraineurs within and between the headache attacks: a case control study.

Authors:  Afshin Samaie; Nabiollah Asghari; Raheb Ghorbani; Jafar Arda
Journal:  Pan Afr Med J       Date:  2012-03-15

5.  N-Methyl-d-aspartate receptor open-channel blockers memantine and magnesium modulate nociceptive trigeminovascular neurotransmission in rats.

Authors:  Jan Hoffmann; Robin James Storer; Jeong-Wook Park; Peter J Goadsby
Journal:  Eur J Neurosci       Date:  2019-06-03       Impact factor: 3.698

Review 6.  Magnesium and Pain.

Authors:  Hyun-Jung Shin; Hyo-Seok Na; Sang-Hwan Do
Journal:  Nutrients       Date:  2020-07-23       Impact factor: 5.717

Review 7.  The Role of Magnesium in Neurological Disorders.

Authors:  Anna E Kirkland; Gabrielle L Sarlo; Kathleen F Holton
Journal:  Nutrients       Date:  2018-06-06       Impact factor: 5.717

Review 8.  The Role of Metabolism in Migraine Pathophysiology and Susceptibility.

Authors:  Olivia Grech; Susan P Mollan; Benjamin R Wakerley; Daniel Fulton; Gareth G Lavery; Alexandra J Sinclair
Journal:  Life (Basel)       Date:  2021-05-01

Review 9.  Cortical spreading depression as a target for anti-migraine agents.

Authors:  Cinzia Costa; Alessandro Tozzi; Innocenzo Rainero; Letizia Maria Cupini; Paolo Calabresi; Cenk Ayata; Paola Sarchielli
Journal:  J Headache Pain       Date:  2013-07-23       Impact factor: 7.277

Review 10.  Headaches and Magnesium: Mechanisms, Bioavailability, Therapeutic Efficacy and Potential Advantage of Magnesium Pidolate.

Authors:  Jeanette A Maier; Gisele Pickering; Elena Giacomoni; Alessandra Cazzaniga; Paolo Pellegrino
Journal:  Nutrients       Date:  2020-08-31       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.